Methods: Studies were systematically searched and identified in the Pubmed and EMBASE databases. Published studies evaluating the efficacy of RDN in patients with RH, reporting at least one outcome of interest were included. Studies were divided into controlled and uncontrolled studies and analyzed using indicated metaanalysis models. Results: We identified 21 eligible studies of 1225 participants. In controlled studies, there was a reduction in mean systolic and diastolic blood pressure (BP) and heart rate (HR) evaluated by ABPM at 6 months of -14 mm Hg (95% CI -23.93--4.07), -8.0 mm Hg (95% CI -14.74--1.26), and -3.77 beats per minute (bpm) (95% CI -7.05--0.50), respectively, compared with medically therapy (for both, P<0.05). Similarly, in uncontrolled studies, reductions in mean systolic and diastolic BP and HR at 6 months were -12.83 mm Hg (95% CI -17.45 to -8.21), -6.77 mm Hg (95% CI -9.24--4.30), and -3.62 bpm (95% CI -5.60--1.63), respectively (for both, P<0.001). Moreover, there were marked improvements in the effect of RDN on cardiac structure, whereas no worsening of renal function was reported and there were few procedural adverse events. Conclusions: RDN demonstrates significant reductions of BP and HR evaluated by ABPM in RH patients. Moreover, it also elicits a marked improvement in cardiac structure without renal impairment. RDN may be a novel and effective approach in treatment of RH with a favorable safety profile.
Beijing Hypertension League Institute
Objectives: Blood pressure variability (BPV) has been identified as an important new risk factor for cardiovascular events. White coat effect (WCE), measured as the first systolic blood pressure (SBP) measurement minus the mean of the second and the third measurements, is a type of BPV within a single visit. We investigated the relationship between WCE and stroke risk in this study. Methods: 2972 participants who had 3 measurements of BP within one single visit were included. Participants were divided into three groups according to their WCE percentiles: Group 1 (WCE 2.5-97.5 , 2.5-97.5th percentiles of WCE), Group 2 (WCE 2.5 , 0-2.4th percentiles of WCE) and Group 3 (WCE 97.5 , 97.6-100th percentiles of WCE). A multiple logistic regression model was used to analyze the relationship between WCE and stroke adjusted for age and BMI groups, gender, smoking status, hypercholesterolemia, SBP, hypertension, diabetes mellitus, IMT thickening, brachial-ankle pulse wave velocity ( baPWV) abnormality and carotid plaque. Results: Traditional risk factors, such as age, gender, hypertension, diabetes, and obesity were related to stroke (P<0.05). CIMT thickening, carotid plaque, ba-PWV abnormality were also related to stroke (P<0.05). Compared to WCE 2.5-97.5 group, the OR for stroke in WCE 2.5 group was 2.78 (95% CI 1.22, 6.36, P¼0.015). After adjusting for age and BMI groups, gender, SBP, diabetes, hypertension, hypercholesterolemia, smoking status, cIMT thickening, carotid plaque and ba-PWV abnormality, the correlation became stronger, OR increased to 2.94 (95% CI 1.16, 7.50, P¼0.023). Conclusions: WCE 2.5 is associated with stroke independently, further studies are needed to be conducted to assess the cause and effect relationship.
GW25-e4136
Lifestyle Modification Combined with Perindopril Therapy on hsCRP and MIF Serum Levels in Patients with Stage 1 Hypertension Chen Zhibin, Zhongfu Ma The 1st Affiliated Hospital of Sun Yat-sen University Objectives: The scientific advisory for hypertension 2013 from ACC/AHA suggested that lifestyle modification in patients with stage 1 hypertension would help to achieve goal of blood pressure control. Few studies focused on chronic inflammation status in stage 1 hypertension patients, while the chronic inflammation status would be relieved by achieving better blood pressure control. In this study we aimed to determine the effect of lifestyle modification combined with perindopril therapy on high sensitivity C-reactive protein (hsCRP) and macrophage inhibitory factor (MIF) serum levels. Methods: 86 cases of level 1 hypertension patients were involved into the study. All the subjects were divided into lifestyle modification group (average age 54.1AE7.2yrs) and perindopril therapy group (average age 56.1AE6.7yrs) by matched pair design. Patients in perindopril therapy group also received lifestyle modification. Peripheral serum from the subjects was collected at the time of enrollment. The same sample collection procedure was conducted after 4 and 8 weeks of intervention. Enzyme-link immune-sorbent assay (ELISA) was used to determine the serum level of hsCRP and MIF. Both groups blood pressure, hsCRP and MIF level was analyze by SPSS 19.0. Results: At the time of enrolled there was no significant difference in blood pressure between two groups (149.6AE6.5/86.6AE9.7mmHg vs 147.7AE7.9/83.8AE11.9mmHg). Both groups' hsCRP and MIF serum level showed no significant difference (hsCRP 3.75AE0.22mg/L vs 3.79AE0.19mg/L, MIF 9.12AE0.24mg/L vs 9.19AE0.18mg/L). Both groups showed better blood pressure control at week 4 and week 8, while patients who receive lifestyle modification combined with perindopril therapy achieved better systolic blood pressure control than those who only receive lifestyle modification at week 8 (123.0AE6.2mmHg vs 137.0AE7.5mmHg) (P<0.05), but there was no significant difference in blood pressure between two groups at week 4. Also both groups' hsCRP and MIF level became lower after intervention. At week 4 patients received both perindopril therapy and lifestyle modification showed significantly lower MIF level (8.32AE0.34mg/L vs 8.85AE0.36mg/L) (P<0.05), while hsCRP level showed no significant difference between two groups (3.26AE0.22mg/L vs 3.54AE0.18mg/L). Both groups' hsCRP and MIF level showed no significant difference at week 8 (hsCRP
Conclusions: Lifestyle modification could achieve good blood pressure control in stage 1 hypertension patients and it could help to lower serum level of hsCRP and MIF. Additional perindopril therapy showed slightly better blood pressure control with lower hsCRP and MIF. But the difference was slight. The results confirmed the important role of lifestyle modification in stage 1 hypertension. But hypotensor therapy is still advised in those with high risk factors, such as diabetes.
GW25-e4417
Correlation among prehypertension, hsCRP and IL-6 in Xinjiang kazakh Wang Lingpeng, Luo Jian Department of cardiology of the First Affiliated Hospital, Xin Jiang Medical University, Urumqi Objectives: To study the relationship among prehypertension, hsCRP and IL-6 in xinjiang kazakh and clinical significance. Methods: The OPD physical-exam persons (n¼396) in 2011 were chosen and divided into the normal group (n¼124), prehypertension group (n¼144) and hypertension group (n¼128). The levels of hsCRP, IL-6, total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and fasting plasma glucose ( FBG) were detected. Results: The comparison of levels of TC, TG, LDL-C, HDL-C, FBG, systolic blood pressure (SBP) and diastolic blood pressure (DBP) among three groups showed that the difference was significant statistically ( all P<0.01).The levels of serum hsCRP and IL-6 were higher in the prehypertension group than those in the normal group (P<0.01), and lower than those in the hypertension group (P<0.01).The result of multiple linear stepwise regression showed that hsCRP and IL-6 were, respectively, correlated to SBP and DBP independently (P<0.001). Conclusions: The patients with prehypertension have higher levels of hsCRP and IL-6 in xinjiang kazakh,which are involved in the development of the Kazak prehypertension.
GW25-e0085
Relationship between Vascular Overload Index and CA-IMT in Hypertensives . Based on the cut-point of IMT>¼ 1.0mm, EH patients were divided into two groups: IMT<1.0mm group (n¼376) and IMT>¼1.0mm group (n¼270). 98 subjects with normal blood pressure served as the control at the mean time. Patients , height, body weight, systolic blood pressure (SBP), diastolic blood pressure (DBP) were recorded. VOI¼1.33*SBP-0.33*DBP-133.3mmHg. Fasting blood glucose, blood lipid profile, liver and renal functions, routine blood test and fibrinogen were also determined. Flow mediated dilation (FMD) of brachial artery (BA) induced by reactive hyperemia was examined by high-resolution vascular ultrasound. The intima media thickness of bilateral carotid artery was also measured. CA-IMT was defined as 1.5mm with any presence of plaque on either side of the carotid artery. All patients underwent echocardiographic exam to detect LVMI. Results: Stepwise multiple regression analysis showed that VOI was an influencing factor for CA-IMT in all subjects. For an increase of 10mmHg of VOI, CA-IMT was thicken by 0.05mm, so as in EH patients. After stratification of age, sex and risk factors, VOI was found to be a persistent influencing factor for CA-IMT in hypertensives. Conclusions: VOI was an important influencing factor for CA-IMT in EH patients.
GW25-e0433
Study Objectives: This study mainly aims to provide an understanding of the status of patients, who go to see a doctor for fluctuation in the blood pressure and suffer from primary hypertension combined with depression, and to shed some light on the correlation between the depression severity and biochemical indexes including the Hcy level. Methods: We use the Patient Health Questionnaire-9 (PHQ-9) to evaluate 165 cases of primary hypertension patients who have been treated with conventional therapy for nearly one week but still suffer from dysarteriotony. According to the results, the cases are divided into three groups, with 34 cases in Group I (without depression), 88 cases in Group II (mild or moderate depression) and 43 cases in Group III (moderately severe depression). Comparisons are made among the three groups in terms of the level of Hcy, LDL, HDL, hs-CRP and FIB. In addition, we make correlation analysis and regression analysis of the scores of PHQ-9 and GAD-7, age, Hcy, LDL, HDL, FIB and hs-CRP. Results: (1) Differences as a result of comparison among the GAD-7 scores and the Hcy levels of the three groups respectively have statistical significance (P<0.05 in both cases). The comparison result indicates that, in terms of the GAD-7 score, difference between Group III and Group I is the biggest (4.71AE0.69), followed by the difference between Goup III and Group II (3.56AE0.56), while the difference between Group I and II is the smallest (-1.15AE0.60). (2) The PHQ-9 score is correlated with age, GAD-7 score and Hcy level (with the correlation coefficient of 0.158, 0.581 and 0.196 respectively and all P<0.05). The GAD-7 score is correlated with the Hcy level (with the correlation coefficient of 0.206 and the P<0.05). (3) Taking the PHQ-9 score as the dependent variable and the GAD-7 score, age and levels of Hcy, LDL, HDL, FIB, hs-CRP as the independent variables, a logistic regression analysis is made and the result indicates that the GAD-7 score, age and the Hcy level enter the regression equation. Conclusions: The Hcy level is a key factor impacting the primary hypertension patients with depression and is positively correlated with depression severity, with more severe depression for higher Hcy level. More attention should be given to the mental health of the primary hypertension patients.
GW25-e0791
Role of AT1 blockade on cardiac ACE2 and mas expression in hypertensive rats Yanling Zhang, Bing Li, Lulu Ma, Junyan Wu Department of Physiology, Institute of Neurobiology, Taishan Medical University, Taian, China
Objectives: Inter-regulation between components of the renin-angiotensin system (RAS) is common, but little is known about the direct regulatory roles of cardiac ACE2 and Mas expression. This study was to determine if the cardiac ACE2, ACE and Mas levels change in hypertensive rats treated with AT1 blocker, losartan and ACE inhibitor, enalapril. Methods: Forty rats were divided into 4 groups: sham operated (n¼10), rats with the aortic ligation (AL, n¼10), AL rats fed enalapril (20mg kg -1 d -1 , n¼10), and AL rats fed losartan (30mg kg -1 d -1 , n¼10). MAP was recorded using a tail-cuff method. After 4 week treatment, levels of ACE2, ACE and Mas receptor in the heart were examined by RT-PCR, western blot and immunohistochemistry. Results: Cardiac ACE mRNA and ACE protein levels were greater in AL rats than in controls (P<0.05). In AL rats with enalapril treatment, cardiac ACE mRNA and its protein levels were decreased (P<0.01). Cardiac ACE2 levels were lower in AL rats than in controls (P<0.01). Both enalapril and losartan increased the levels of cardiac ACE2 expression and decreased MAP, however, losartan seemed more efficient in control of MAP compared to enalapril. Interestingly, Mas mRNA rose in AL rats treated with losartan, but not with enalapril.
Conclusions: Our findings demonstrate that enalapril and losartan increase the ratio of cardiac ACE2/ACE levels. Losartan significantly elevates the cardiac Mas expression but not enalapril. These results indicate that the protective effect of AT1 blockade on the heart may occur by increasing the activity of the cardiac ACE2-Ang (1-7) -Mas axis of the RAS.
GW25-e1075
The incidence of cough in hypertensive population treated with ACEI (Lisinopril) Objectives: To observe the incidence and start time of cough in hypertensive population treated with single Lisinopril. To investigate the relationship between cough and gender or age. Methods: Ninety-seven mild hypertensive patients were enrolled to receive single Lisinopril treatment after elution for three weeks. They were demanded follow-up visit every two weeks for 8 weeks after informed consent. The blood pressure (BP) was recorded as the average of 2 readings in each posture during each visit (standing posture following sitting posture). The mean value of BP and pulse in each posture and the start day of cough were recorded. All analyses were conducted using the SPSS package (version 13.0). Results: Fifty male and 47 female with the course of hypertension from 5 months to 26 years were enrolled. The average age was 48.40AE8.87 years. The BP after elution was (138.79AE14.29/94.42 AE6.88) mmHg (sitting posture) and (139.28AE15.50/98.11 AE8.38) mmHg (standing posture). The pulse was 72.25AE6.61/min (sitting posture) and 73.75AE6.72/min (standing posture). There were 42 patients (22 male and 19 female) happen to cough after admitted Lisinopril. The incidence of cough adverse effect was 44.00% in male and 42.55% in female. The start day of cough were: 14 cases (33.3%) in 5 day; 12 (28.6%) in 6-10 days, 7 (16.7%) in 11-20 days, 5 (11.9%) in 21-30 days, and 4 (9.5%) in 31-40 days. There was no significant difference in the percentage of cough presented by age, gender or the course of hypertension. Conclusions: The incidence of cough adverse effect was 44.0% in male and 42.55% in female with single Lisinopril treatment. Cough present was high in 10 days (61.9%). Cough adverse effect of Lisinopril was no significant difference in age, gender or the course of hypertension. Careful clinical observation is recommended when Lisinopril or other ACEI has to be prescribed.
GW25-e1665 Association between Plasma Homocysteine Levels and Blood Pressure Variability in Patients with Primary Hypertension
Gu Beiyin, Jiang Li Shanghai Tongren Hospital, ShangHai Jiao Tong University Objectives: To investigate the association between homocysteine (Hcy) level and blood pressure variability (BPV) in patients with primary hypertension. Methods: A total of 154 patients diagnosed with primary hypertension (mean age: 56.48AE7.95 years; 103 males) were enrolled. All patients underwent blood sample tests and 24h ambulatory blood pressure (ABP) monitoring and were divided into two groups according to their Hcy levels: normal-Hcy group (n¼79) and high-Hcy group (n¼75). Indices including age, gender, smoking history, blood biochemical test data, and ABP, were statistically compared. Results: The percentage of male patients in the high-Hcy group (82.7%) was significantly greater than that in the normal-Hcy group (P<0.001). No office BP data differed significantly between the two groups. In the high-Hcy group, the night-time SBP variability (14.67AE5.74 mmHg) was significantly higher than in the normal-Hcy group (P¼0.034). In addition, the morning pressure surge in the high-Hcy group (20.62AE15.01 mmHg) was significantly higher than in the normal-Hcy group (P¼0.001). Further, multiple linear regression showed that the interaction between Hcy and the night-time SBP variability or the morning pressure surge was still significant after adjusting for the effect of age, gender, smoking and laboratory data. The night-time SDSBP and the morning pressure surge were both positively and significantly related to Hcy (P¼0.022 and P¼0.005, respectively). Conclusions: Plasma Hcy levels were associated with the variability in night-time SBP and the morning pressure surge in hypertensive patents. These findings suggest that increased night-time BPV and morning pressure surge may be a mediator for the link between hyperhomocysteinemia and target organ damage.
GW25-e2165
Left Ventricular Function Changes along with the Hypertension Progress in 2K-2C Rats Liu Donghong, Liu Donghong, Liu Yanqiu, Li Cuilin, Yao Fengjuan, Lin Hong The 1st Affiliated Hospital of Sun Yat-sen University Objectives: Cardiac remodeling and myocardial dysfunction come with hypertension is well known. However it is not clear what is going on with hypertension developed. Our study is to evaluate the left ventricular function changes along with the hypertension progress in two kidney-two clip (2k-2c) rats. Methods: There were 18 rats assigned to a sham group and 2k-2c group (n¼9, each) for 12 weeks. Blood pressure, weight, cardiac morphological changed and left ventricular ejection fraction, and diastolic function indexes were recorded at 1w, 4w, 8w and 12w. Results: Along with hypertension progress, left ventricular mass indexes increased according with blood pressure elevated significantly (P<0.001, compared to sham group). But left ventricular ejection fraction has no obvious difference between the
